⭐️⭐️⭐️⭐️⭐️ "A total no brainer"

⭐️⭐️⭐️⭐️⭐️ "Love this, so easy."

Spots is the easy way to track your skin, mole and cancer changes.

Spots Global Cancer Trial Database for soft tissue sarcoma adult

Every month we try and update this database with for soft tissue sarcoma adult cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Study titleNCT IDConditionsInterventionsEligibilityOrganizationLink
Prospective Identification of Predictive Biomarkers of Trabectedin Efficacy in Non-L Soft-tissue Sarcoma PatientsNCT04008238
Soft Tissue Sar...
Undifferentiate...
Epithelioid Sar...
Solitary Fibrou...
Hemangioendothe...
Desmoplastic Ro...
Synovial Sarcom...
Trabectedin
18 Years - Institut Bergonié
Radiation Effects on BoneNCT03134742
Soft Tissue Sar...
Control Group
CT Scan
DEXA Scans
CT and DEXA Sca...
18 Years - 89 YearsState University of New York - Upstate Medical University
Quality of Life in Patients With Non-adipocyte Soft Tissue Sarcoma Under Palliative Chemotherapy or PazopanibNCT03735758
Soft Tissue Sar...
pazopanib or gu...
18 Years - GWT-TUD GmbH
Propranolol and Pembrolizumab in Advanced Soft Tissue Sarcoma PatientsNCT05961761
Soft Tissue Sar...
Angiosarcoma
Undifferentiate...
Propranolol
Pembrolizumab
18 Years - Herlev and Gentofte Hospital
Sarcomas and DDR-Inhibition; a Combined Modality StudyNCT05116254
Soft Tissue Sar...
AZD1390 + radio...
AZD1390 + durvl...
18 Years - The Netherlands Cancer Institute
Apatinib for Advanced Soft Tissue Sarcoma Patients: a Phase 2, Multicenter TrialNCT03104335
Soft Tissue Sar...
Advanced Cancer
Apatinib
16 Years - Peking University People's Hospital
Combined Treatment of Patients With Soft Tissue Sarcoma Including Preoperative Stereotactic Radiation Therapy and Postoperative Conformal Radiation TherapyNCT04330456
Soft Tissue Sar...
Preoperative st...
Surgery
Postoperative c...
18 Years - 75 YearsN.N. Petrov National Medical Research Center of Oncology
Apatinib for Advanced Soft Tissue Sarcoma Patients: a Phase 2, Multicenter TrialNCT03104335
Soft Tissue Sar...
Advanced Cancer
Apatinib
16 Years - Peking University People's Hospital
Quality of Life in Patients With Non-adipocyte Soft Tissue Sarcoma Under Palliative Chemotherapy or PazopanibNCT03735758
Soft Tissue Sar...
pazopanib or gu...
18 Years - GWT-TUD GmbH
Low Dose Continuous Cyclophosphamide vs Standard Doxorubicin in Advanced Sarcoma Elderly PatientsNCT04656262
Soft Tissue Sar...
Cyclophosphamid...
Doxorubicin
70 Years - Istituto Oncologico Veneto IRCCS
A Study of Surufatinib in the Treatment of Advanced Soft Tissue SarcomaNCT06110650
Soft Tissue Sar...
Surufatinib
18 Years - Fudan University
Study of a Cohort of Cases of Synovial Sarcoma Treated in the Orthopedic Surgery and Traumatology Department of the Hospital de Sant Pau Between 1983 and 2016NCT03833037
Soft Tissue Sar...
Soft tissue sar...
10 Years - 100 YearsFundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau
Fluorescent Aided Resection and Evaluation of Soft Tissue Sarcomas (FLARES)NCT06252727
Soft Tissue Sar...
Soft Tissue Sar...
Aminolevulinic ...
18 Years - University of California, Davis
Blood and Tissue Extraction for Immunological Examinations During Neoadjuvant Therapy of Soft Tissue SarcomasNCT06385288
Soft Tissue Sar...
Blood and tissu...
neoadjuvant The...
18 Years - University Hospital Tuebingen
Efficacy and Safety of Anlotinib in Adjuvant Therapy for High-grade Soft Tissue SarcomaNCT03951571
Soft Tissue Sar...
High Grade Sarc...
Anlotinib Hydro...
Placebo Oral Ta...
18 Years - Fudan University
Sarcomas and DDR-Inhibition; a Combined Modality StudyNCT05116254
Soft Tissue Sar...
AZD1390 + radio...
AZD1390 + durvl...
18 Years - The Netherlands Cancer Institute
Pre-operative RadiothErapy for Soft Tissue SarcOmasNCT04617327
Soft Tissue Sar...
Hypofractionati...
18 Years - McGill University Health Centre/Research Institute of the McGill University Health Centre
Combination of Nivolumab Plus Relatlimab in Patients With Advanced or Metastatic Soft-tissue Sarcoma: a Proof-of-concept Randomized Phase II StudyNCT04095208
Soft Tissue Sar...
Advanced Cancer
Association of ...
Nivolumab
18 Years - Institut Bergonié
Impact of Locoregional Treatment of Soft Tissue Sarcoma on Status of Patients Aged 70 Years and OverNCT03077178
Soft Tissue Sar...
Geriatric asses...
70 Years - Institut Bergonié
Combination of Nivolumab Plus Relatlimab in Patients With Advanced or Metastatic Soft-tissue Sarcoma: a Proof-of-concept Randomized Phase II StudyNCT04095208
Soft Tissue Sar...
Advanced Cancer
Association of ...
Nivolumab
18 Years - Institut Bergonié
Precise Local Injection of Anti-cancer Drugs Using Presage's CIVO Device in Soft Tissue SarcomaNCT03056599
Soft Tissue Sar...
Multiple drug m...
CIVO device
18 Years - Presage Biosciences
Low Dose Continuous Cyclophosphamide vs Standard Doxorubicin in Advanced Sarcoma Elderly PatientsNCT04656262
Soft Tissue Sar...
Cyclophosphamid...
Doxorubicin
70 Years - Istituto Oncologico Veneto IRCCS
Logo

Take Control of Your Skin and Body Changes Today.

Try out Spots for free, set up only takes 2 mins.

spots app storespots app store

Join others from around the world: